The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sarah Rodriguez and Michael P Blair.
Sarah Rodriguez
Connection Strength
4.914
Michael P Blair
  1. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
    View in: PubMed
    Score: 0.763
  2. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.713
  3. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248.
    View in: PubMed
    Score: 0.681
  4. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
    View in: PubMed
    Score: 0.340
  5. Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec; 60(6):e75-e78.
    View in: PubMed
    Score: 0.242
  6. Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen. J Clin Med. 2023 Feb 03; 12(3).
    View in: PubMed
    Score: 0.230
  7. Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
    View in: PubMed
    Score: 0.229
  8. Laser Prophylaxis in Patients with Stickler Syndrome. Ophthalmol Retina. 2022 04; 6(4):263-267.
    View in: PubMed
    Score: 0.211
  9. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
    View in: PubMed
    Score: 0.206
  10. Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
    View in: PubMed
    Score: 0.198
  11. A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023.
    View in: PubMed
    Score: 0.196
  12. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
    View in: PubMed
    Score: 0.194
  13. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2020 Apr 01; 145(4).
    View in: PubMed
    Score: 0.189
  14. Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity". Taiwan J Ophthalmol. 2019 Apr-Jun; 9(2):136-137.
    View in: PubMed
    Score: 0.176
  15. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
    View in: PubMed
    Score: 0.175
  16. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.